VANSEN PHARMA INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
VANSEN PHARMA INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $2.48 million as of 2013-09-30, per its 10-Q filed 2013-12-04.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2013-12-04
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $2.48M.
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $268.37K.
- 2013-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $256.08K.
- 2012-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $250.07K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2013-09-30 | $2.48M 10-Q · filed 2013-12-04 |
| 2013-06-30 | $268.37K 10-Q · filed 2013-08-19 |
| 2013-03-31 | $256.08K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $250.07K 10-Q · filed 2013-08-19 |
| 2012-09-30 | $242.67K 10-Q · filed 2012-11-15 |
| 2012-06-30 | $233.78K 10-Q · filed 2012-08-20 |
| 2012-03-31 | $225.07K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $212.92K 10-K · filed 2013-04-12 |
| 2011-09-30 | $204.95K 10-Q · filed 2011-11-18 |
| 2011-06-30 | $199.30K 10-Q · filed 2011-08-19 |
| 2010-12-31 | $187.86K 10-K · filed 2012-03-30 |